date:Aug 28, 2012
ourished.
We had to send a lot of supportive data to be included in the reimbursement scheme,Sande Mathisen said.Exposure is still growing there after we were accepted 1.5 years ago.
The 2000mg drink will target those with chronic diseases.
She said the company was seeingincredible resultsfrom studies, although most of them were yet to be peer-reviewed. A list of ongoing studies can be foundhere.
Strong scientific and IP platform
Smartfish is investing in building up a strong scientific and